EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

C9orf72 protein quality control by UBR5 ‐mediated heterotypic ubiquitin chains

Julia Jülg iD, Dieter Edbauer, Christian Behrends iD

EMBO reports · 2023

DOI: 10.15252/embr.202255895 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EMBO reports, 2023. Verfasst von Julia Jülg und 2 weiteren Autor:innen. Beteiligte Einrichtung: Munich Cluster for Systems Neurology, Medical Faculty, Ludwig-Maximilians-Universität München, Munich, Germany. Hauptthemen laut MEDLINE: Frontotemporal Dementia, Amyotrophic Lateral Sclerosis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hexanucleotide repeat expansions within C9orf72 are a frequent cause of amyotrophic lateral sclerosis and frontotemporal dementia. Haploinsufficiency leading to reduced C9orf72 protein contributes to disease pathogenesis. C9orf72 binds SMCR8 to form a robust complex that regulates small GTPases, lysosomal integrity, and autophagy. In contrast to this functional understanding, we know far less about the assembly and turnover of the C9orf72–SMCR8 complex. Loss of either subunit causes the concurrent ablation of the respective partner. However, the molecular mechanism underlying this interdependence remains elusive. Here, we identify C9orf72 as a substrate of branched ubiquitin chain‐dependent protein quality control. We find that SMCR8 prevents C9orf72 from rapid degradation by the proteasome. Mass spectrometry and biochemical analyses reveal the E3 ligase UBR5 and the BAG6 chaperone complex as C9orf72‐interacting proteins, which are components of the machinery that modifies proteins with K11/K48‐linked heterotypic ubiquitin chains. Depletion of UBR5 results in reduced K11/K48 ubiquitination and increased C9orf72 when SMCR8 is absent. Our data provide novel insights into C9orf72 regulation with potential implication for strategies to antagonize C9orf72 loss during disease progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Frontotemporal DementiaAmyotrophic Lateral SclerosisHumansC9orf72 ProteinUbiquitinCarrier ProteinsProteinsUbiquitin-Protein LigasesMolecular Chaperones

Stichwörter der Autor:innen

BAG6 complexC9orf72K11/K48-linked ubiquitinUBR5heterotypic ubiquitin chains

Substanzen

C9orf72 ProteinUbiquitinCarrier ProteinsProteinsUBR5 protein, humanUbiquitin-Protein LigasesBAG6 protein, humanMolecular ChaperonesC9orf72 protein, human

Autor:innen und Institutionen

  • Munich Cluster for Systems Neurology, Medical Faculty, Ludwig-Maximilians-Universität München, Munich, Germany.
  • German Center for Neurodegenerative Diseases Munich, Munich, Germany.

ORCID-Profile: Julia Jülg, Christian Behrends

Zitieren

APA

Jülg, J., Edbauer, D., & Behrends, C. (2023). C9orf72 protein quality control by UBR5 ‐mediated heterotypic ubiquitin chains. EMBO reports. https://doi.org/10.15252/embr.202255895

Vancouver

Jülg J, Edbauer D, Behrends C. C9orf72 protein quality control by UBR5 ‐mediated heterotypic ubiquitin chains. EMBO reports. 2023. doi:10.15252/embr.202255895

BibTeX
@article{Jlg2023,
  author = {Jülg, Julia and Edbauer, Dieter and Behrends, Christian},
  title = {C9orf72 protein quality control by UBR5 ‐mediated heterotypic ubiquitin chains},
  journal = {EMBO reports},
  year = {2023},
  doi = {10.15252/embr.202255895}
}
Kostenlos starten →